Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-24 @ 2:32 PM
Ignite Modification Date:
2025-12-24 @ 2:32 PM
NCT ID:
NCT03686059
Brief Summary:
Ocular surface disease is a common adverse effect of systemic isotretinoin therapy.
The investigators consider that punctal plugs and Omega 3 is a good line for treatment of ocular surface disease associated with systemic isotretinoin therapy
Detailed Description:
Subjective and objective evaluation of ocular surface disease was done at baseline ,1 and 3 months of the study .
Study:
NCT03686059
Study Brief:
Protocol Section:
NCT03686059